429 related articles for article (PubMed ID: 19926709)
1. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity.
Krishnan AV; Moreno J; Nonn L; Swami S; Peehl DM; Feldman D
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V74-80. PubMed ID: 18290727
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract][Full Text] [Related]
4. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.
Krishnan AV; Moreno J; Nonn L; Malloy P; Swami S; Peng L; Peehl DM; Feldman D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):694-702. PubMed ID: 17229571
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
Krishnan AV; Feldman D
Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
Moreno J; Krishnan AV; Peehl DM; Feldman D
Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
Moreno J; Krishnan AV; Feldman D
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):31-6. PubMed ID: 16024246
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
9. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells.
Nonn L; Duong D; Peehl DM
Carcinogenesis; 2007 Jun; 28(6):1188-96. PubMed ID: 17151092
[TBL] [Abstract][Full Text] [Related]
11. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
Wang JY; Swami S; Krishnan AV; Feldman D
Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
Nonn L; Peng L; Feldman D; Peehl DM
Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.
Krishnan AV; Srinivas S; Feldman D
Dermatoendocrinol; 2009 Jan; 1(1):7-11. PubMed ID: 20046582
[TBL] [Abstract][Full Text] [Related]
14. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
15. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
16. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-diindolylmethane induction of p75NTR-dependent cell death via the p38 mitogen-activated protein kinase pathway in prostate cancer cells.
Khwaja FS; Wynne S; Posey I; Djakiew D
Cancer Prev Res (Phila); 2009 Jun; 2(6):566-71. PubMed ID: 19470787
[TBL] [Abstract][Full Text] [Related]
18. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
19. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
